C 型肝炎治療ガイドライン (第 5版)C 型肝炎治療ガイドライン (第5版) 2016 年5 月 日本肝臓学会 肝炎診療ガイドライン作成委員会 編
03 01-病毒性肝炎
-
Upload
yansongfan -
Category
Documents
-
view
406 -
download
13
Transcript of 03 01-病毒性肝炎
-
viral hepatitis
-
HAVHAVRNAPicornavirus198172RNAHeparnavirusHAVHAV27~32nmRNA
-
HAV HAV20
-
HAV11IgM36IgG
-
HBV HBVDNAHepadnavirusDNA
-
1525nm22nm50230nm42nm HBV120000
-
HBVDane HBV HBV
-
DaneDane HBsAg DNADNAPHBcAg HBeAg
-
HBVHBV DNADNA 3182bpL SCPXS HBV
-
HBV
-
HBV DNA HBVRNADNA
-
HCV 1989HCV1991HCVFlavivirus
-
HCVHCVHCVvirus-like particlesVLPsHCV VLPs55nm 33nm RNA
HCV
-
HCVCEP7NS NS2NS3NS4NS5 NS4NS5AB55NCR3 3NCR
HCV
-
CE1E2NS2-NS5
-
5NCRHCV3NCRHCV RNA
-
quasispeciesHCVRNA
-
Simmonds HCVHCV16 1231a1b1c2a2b2c3a3b4a5a6a1994HCV
-
HDV HDVArenaviridae Deltavirus HDV
-
HDV3537nmDNA HBsAg
-
HDVHBVDNAWHVHDV RNAHBVHDVHBV
-
HDVRNA1679bp-antigenomic strandantisense strandRNAHDVHDVRNAORF-ORF5HDAgORF
-
HDVHDV3HDVAB
-
HDV RNARNA
RNAPRNARNARNA HDV RNA GRNAAG-RNAXGAGRNA
-
HDVHBVHBVHBVHDVHDVHBV
-
HEV1989HEV Calicivirus
-
CaliciviridaeHEVNodaviridaehepatitis E-like viruses
-
HEV HEVHEV2734nm
-
HEVRNA 7.5kb3ORFORF-1ORF-2ORF-3
HEV
-
HGVGBV-C1995HGVGBV-C/HGVRNA100nm
-
l997NishiZdwdTT500bpN22TTV 19970KamotoTTVTTV
-
TTVDNA3050nmDNA
TTVSF-21
-
TTV3.8kb1.2kb2.6kbORFORF1ORF2
TTV
-
TTVTTV6G1-G6G1 G2G311
-
2ALT1
-
1988HAV
-
HBV
-
HBs
-
HBsAg
-
HCV
-
HCV
-
HDVHBV
-
HBVHDVHBV HBVHDVHBV
-
HEV
-
HEV 1988~1989
-
HAVNKCD8+THAV
-
HBVT/B/CD8+HBcAgMHC-CD4+BHBsAgHBcAgMHC-B-HBs
-
HCVHCV HCVCD8+HCV
-
HCVHCVHCVHCV
-
CD8+ THDV
-
HEVHEV()TCTLNK
-
HCV
-
1 2 3 4
-
PN BN3-P-PBN-P-CBN-C-CBN14S14
-
14GradeG14StageS
-
G12S02G3S13G4S24
-
() 1/2
-
1.VP2. 12
-
TCTLThHBsAb Arthus
-
-GABA
-
DIC
-
DIC
-
1457d26 12
-
5
-
Co-infection Superinfection
-
12
- 0.2%~0.5%: HBVC ; , PTA
-
acute liver failure, ALF fulminant hepatitis :2
-
subacute liver failure, SALF: 15d26 : : : Hb3
-
acute-on-chronic liver failure, ACLFchronic liver failure, CLF
-
TB171mol/L17.1mol/L 30PTA40
-
/ 20PTA30
-
PTA20
-
-GTGGTALPAKPTBACHOALT,ASTPTPTA60
-
Child-Pugh AChild-Pugh BC35g/LA/G1.035mol/L60%
-
HBVHBsAg
-
ALTASTALTALP-GTCHE
-
171mol/L/A/G
-
PTPTA40%PTHAPC--CLN
-
-HAV IgMHAVHAV-HAV IgG
-
HBsAg-HBs HBsAgHBVHBsAgHBVS-HBsHBV-HBsHBVHBVHBsAg-HBsHBsAg-HBs
-
HBeAg-HBe HBeAgHBV-HBeHBVHBV DNADNACHBeAg
-
HBcAg-HBc HBcAgDaneHBV-HBc IgMHBV-HBc IgG
-
HBV DNA
-
HBsAg HBsAg400 HBcAg HBcAg 400 HBVHBsAgHBcAgHBV DNA
-
-HCVHCV-HCV IgM-HCV IgGHCV1~2HCV RNA
-
HDAg-HDVHDAg-HDV IgM-HDV IgGHBVHDV-HBc IgM-HDVHBVHDV-HBc IgM-HDVHDV RNAHDV
-
-HEV IgM-HEV IgGHEVRT-PCRHEV RNA
-
PCR
-
BTHBVHCV
-
HBsAg
-
ALT6
-
HBsAgB3
-
BB/
-
() : 21526
-
3
-
B
-
-HAV IgMHAV-HAV IgM
-
HBsAg-HBs-HBc IgM-HBc IgG a.HBeAgHBsAgHBV DNAHBeAg-HBeALT b.HBeAgHBsAgHBV DNAHBeAg-HBeALT
- 3.a.Child-Pugh AALTASTb.Child-Pugh BC35 mol/LALTAST(PTA)
- 4.HBV a.HBVHBsAgHBV DNAHBeAg-HBe13ALTASTb.HBsAgHBsAgHBeAg-HBeHBV DNA(PCR)13ALT:Knodell ( HAI)
-
HCV RNA-HCV-HCV/HCV RNA
-
HDV HBVHBV-HDV IgM-HDV IgG/HDV AgHDV RNAHDVHBVHBsAgHDV RNA/HDV Ag-HDV IgM-HDV IgGHDV RNA/HDV Ag-HDV IgGHDV RNAHDV RNA/HDV Ag
-
-HEV-HEV1:20RT-PCR/HEV RNA-HEV IgM
-
310%~40%HBV70%1%5%10%40%
-
50%~70%80%
-
8001000mg/d
-
HBVALTHCV RNA+/-HCV+ALT
-
2
-
35MU5MU311PEG1118
-
ALTHBV DNAHBeAgHBsAgALTHBV DNAHBeAgHBsAg612612ALTHBV DNA
-
ALTHCV RNAALTHCV RNAHCV RNA ALTALTHCV RNA612612ALTHCV RNA
-
24h
-
()(): :
-
()HBV
-
A(lamivudine)100mg (adefovir dipivoxil)10mg (entecavir)0.5 mgYMDD1mg 10 (telbivudine) 600 mgFDAB
-
: HBeAg:HBeAg 1; HBeAg:2 : ()
-
5%10%BCK
-
-G-I1mg10U10500ml1/d14HGF120200mg/d E1 (PGE1)1020g/d
-
:( )
-
:
-
HBV(HBV DNA104 /ml)
-
artificial liver support system ALSS
-
PTA20%40%50109/L
-
DIC
-
3HBsAgHCV RNA/ / HBIG -HBV IgG
-
//
-
AFPPTA HBIG
-
:
-
18 64, 39, 5
-
HBsAg (+)T 37P70/BP100/70mmHg1.5cm: (+) (-)84mol/L 60mol/LALT200u/L
-
?? ()
-
..2005Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B.Zhonghua Ganzangbing Zazhi,2005,13:881-891...200513881-891PolsonJ,LeeWM.AmericanAssociationfortheStudyofLiverDisease.(AASLD)PositionPaper:TheManagementofAcuteLiverFailure.Hepatology.2005,41:1179-97